Previous investigations have revealed evidence for species-specificity among various mammalian insulins in immunologic reactions (1) (2) (3) (4) (5) . For this reason, immunoassay of plasma insulin (6) (7) (8) (9) (10) in any species generally requires that the insulin employed in standard solutions be derived from the same species. Immunoassay of plasma insulin in man has been carried out by comparing the effects of unknown plasma samples with those of standard solutions of human insulin in their ability to inhibit competitively the binding of I131-labeled beef insulin by guinea pig antibodies to beef insulin (7) (8) (9) (10) . Since supplies of human insulin are relatively scarce, the immunoassay of endogenous plasma insulin in man would be expedited if an animal insulin in more plentiful supply could be substituted as a standard for human insulin. Insulins from four different ungulate species (beef, hog, sheep, horse) have been found to react quantitatively with human antiserums to beef-pork insulin in a manner that could be correlated (5) with the similarity or dissimilarity of the amino acid sequences as elucidated by Harris, Sanger and Naughton (11) . Of these four insulins, pork insulin (11) resembles human insulin (12) most closely in amino acid sequence, differing only in the C-terminal residue of the B chain (alanine in pork insulin, threonine in human insulin). The other animal insulins differ from human insulin also in one or more of the 8 to 10 positions of the A chain. It seemed worthwhile, therefore, to examine various antiserums for similarity of reaction of pork and human insulin. The present communication describes insulin antiserums obtained from guinea pigs immunized with crystalline pork insulin that react identically with human insulin and pork insulin in respect to the competitive inhibition of binding of pork insulin-131.
METHODS
Guinea pigs were injected subcutaneously with approximately 5 U of crystalline pork insulin (Lilly, lot no. 499667) or crystalline beef insulin (Lilly, lot no. 535664) emulsified in 0.2 ml mannide monooleate or 10 U of protamine zinc beef insulin (Squibb) without adjuvant at intervals of 2 to 10 weeks to a total of 4 to 7 doses. Approximately 10 ml heparinized blood was taken by cardiac puncture about 2 weeks after insulin inj ections. Hypoglycemic reactions were virtually obviated by sprinkling table sugar over the chow and by adding glucose to the drinking water for 24 hours after insulin injections.
Human antiserums to insulin were obtained from insulin-resistant and nonresistant diabetic subjects treated with commercial mixtures of beef-pork insulin. Serums were taken at least 24 hours after the last injection of insulin and allowed to stand at 40 C for at least 8 weeks to permit destruction of any residual animal insulin by the plasma (10, 13) .
All dilutions of antiserum and insulin were prepared in veronal buffer, ionic strength 0. Insulin-I"l was prepared from crystalline beef or crystalline pork insulin as described previously (10) . All insulin-antiserum mixtures in the same experiment were prepared with identical concentrations of I"-llabeled insulin and antiserum (added last in all cases) but varying concentrations of unlabeled insulin as indicated. After incubation for 3 to 5 days at 40 C, insulin-antiserum mixtures were applied to strips of Whatman 3 MM paper for chromato-electrophoresis as described previously (10, 13) . After 45 to 90 minutes, antibody-bound insulin has moved about 3 inches from the site of application (origin) whereas unbound (free) insulin remains adsorbed to the paper at the origin. After drying, the paper strips were assayed for radioactivity in an automatic strip counter. Areas under the peaks of free and bound insulin-I'" were determined with a planimeter.
RESULTS
Antiserums from guinea pigs immunized with beef insulin were tested for their ability to discriminate between unlabeled beef insulin and Fisher human insulin competing against beef insulin-I'31 ( Figure 1 ). All data were obtained in a single experiment in which the same solutions of beef and human insulin were used for all antiserums. It is evident that beef insulin competed more strongly than human insulin in all antiserums and that the relative activity of beef and human insulin varied considerably among the three antiserums. The reaction of pork insulin was intermediate between that of human insulin and that of beef insulin. Depending on the antiserum tested and on the insulin concentration, it required from about 1.5 to 20 times as high a concentration of human insulin as beef insulin to reduce the ratio bound beef insulin-I131/free beef insulin-I'13 (B/F) to the same value. The results on guinea pig serum no. 49 625 were essentially the same (with respect to the relative activities of beef and human insulin) as those reported previously in another experiment with the same antiserum (10) . A somewhat larger amount of beef insulin-I'3' was used in the present experiment so that the initial ratio (in the absence of added unlabeled insulin) is slightly below that obtained previously. To evaluate the influence of temperature on the difference in reactivities of beef and human insulin, another guinea pig antibeef insulin serum was studied in a separate experiment by incubation at 40 and 370 C (Figure 2 ). Although the B/F ratio at all concentrations was higher at 40 than at 370 C, as reported previously for human antiserums (14) , there was no striking difference in the relative reactivities of the two insulins at the two temperatures.
Antiserums from human subjects treated with commercial mixtures of beef-pork insulin were studied in a similar manner (Figure 3) Yet, it was concluded that "agreement between the immunoassay values for human insulin against beef insulin standards when either guinea pig or human antiserum was used was demonstrable." It is difficult to reconcile the authors' conclusion that human insulin and beef insulin react similarly in guinea pig and human insulin antiserums with the results of their studies on a single human antiserum which clearly dispute such a conclusion. "Agreement" of the order of magnitude reported hardly refutes our previous contention that beef insulin cannot be used indiscriminately as a standard for human insulin in immunologic systems (10) . The more extensive data of the present study confirm previous observations that human insulin generally competes less strongly than beef insulin against the binding of beef I131-insulin in antiserums from human subjects or from guinea pigs immunized with beef insulin and that the relative reactivities of human and beef insulin may vary widely among different antiserums. Furthermore, Burrows, Peters and Lowell (4) have reported on two human antiserums in which human insulin produced either no effect or only very slight effect on the binding of beef insulin-I"3'. Earlier, Lowell (2) had reported that administration of human insulin to an insulin-resistant patient was effective in lowering blood sugar although beef insulin in the same dosage was completely ineffective, and Lerman (17) had emphasized that insulin antibodies in insulin-resistant human subjects are weakest when tested against human insulin. More recently we have directly compared human insulin binding (employing human insulin-I'13 with unlabeled human insulin) and beef insulin binding (employing beef insulin-I13' with unlabeled beef insulin) in eight human antiserums (18) . Weaker binding of human insulin than of beef insulin was observed in almost all cases. It is only to be expected that the cross reaction of unlabeled human insulin with I'31-labeled beef insulin would be still weaker.
The evidence of previous studies and that of the experiments reported here clearly refute the notion that beef and human insulin react similarly with human antibeef-pork insulin serums or with guinea pig antibeef insulin serums.
Grodsky and Forsham (16) also studied the Fisher preparation of human insulin, which they report as having been recently assayed in the Lilly Research Laboratories at 4.08 U per mg.2 Applying this new assay to a figure previously published by the present authors, Grodsky and Forsham concluded 1) that the beef insulin and human insulin curves could be superimposed and -Based on a reference standard of 27 to 29 U per mg. therefore that these two insulins reacted identically against beef insulin-I'31 in guinea pig antibeef insulin antiserums, and 2) that the proportionality between beef and human insulin in the original data "varied only from 0.45 to 0.55 regardless of the point chosen along the curves for the calculations." However, as is evident from the reproduced figure in their paper as well as from the original data, this statement is inaccurate, since the proportionality factor ranged from about 0.3 to 0.6. It might also be noted that the original figure showed values for the Tietze insulin falling along the same curve as the Fisher insulin, but the former were omitted from the reproduced figure. A repeat experiment with the same antiserum (GP no. 49 625), presented in the current study (Figure 3) (19) and yet reacts in the immunologic system (20 However, aside from differences in amino acid sequences, the various insulins might well exhibit differences in secondary or tertiary structure as well, a suggestion supported by distinct immunochemical differences between sperm whale and pork insulin (21) , which are reported as identical in amino acid sequences ( 11, 22 (23) . However, an additional contribution of the C-terminal residue of the B chain to antigenicity of pork insulin can certainly not be excluded. Furthermore, the similarity of pork and human insulin does not extend to the reaction against beef insulin-I13' (or even against pork insulin-I'31) in beef insulin-immunized guinea pigs or humans (5). Since beef and pork insulin contain the same C-terminal amino acid in the B chain, no differences in antigenicity of this group can be expected and we must again postulate structural differences beyond those of specific amino acid sequence to account for all findings. In any event, these theoretical speculations are outside the practical purpose of the present study, namely, the procurement of antiserums suitable for immunoassay of endogenous plasma insulin in man under conditions that dispense with the need for human insulin.
SUMMARY AND CONCLUSIONS 1. Previous observations of variable and occasionally marked differences in reaction of beef insulin and human insulin competing with beef insulin-I'13 in human antibeef-pork insulin serums and in guinea pig antibeef insulin serums are confirmed and extended.
2. Antiserums from guinea pigs immunized with pork insulin exhibit close similarity of reaction with pork and human insulin. In two antiserums, pork and human insulin reacted identically when competing against the antibody-binding of pork 
